ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,631,278 | +29.1% | 161,974 | +2.4% | 0.26% | +43.3% |
Q2 2023 | $61,672,044 | +2.5% | 158,243 | -2.0% | 0.18% | -1.1% |
Q1 2023 | $60,150,060 | -3.3% | 161,442 | -1.7% | 0.18% | -6.7% |
Q4 2022 | $62,189,112 | +13.3% | 164,161 | -0.6% | 0.19% | -2.0% |
Q3 2022 | $54,869,000 | -13.7% | 165,124 | -1.6% | 0.20% | +4.2% |
Q2 2022 | $63,607,000 | +18.6% | 167,882 | -1.3% | 0.19% | +36.0% |
Q1 2022 | $53,643,000 | +44.2% | 170,129 | +60.2% | 0.14% | +59.8% |
Q4 2021 | $37,198,000 | +12.6% | 106,222 | -2.9% | 0.09% | +2.4% |
Q3 2021 | $33,027,000 | -1.2% | 109,358 | -1.5% | 0.08% | -1.2% |
Q2 2021 | $33,436,000 | +6.9% | 111,056 | -2.2% | 0.09% | -4.4% |
Q1 2021 | $31,267,000 | -9.4% | 113,538 | -3.2% | 0.09% | -3.2% |
Q4 2020 | $34,507,000 | +12.8% | 117,333 | +0.7% | 0.09% | +2.2% |
Q3 2020 | $30,595,000 | +12.7% | 116,541 | -3.3% | 0.09% | 0.0% |
Q2 2020 | $27,140,000 | +67.5% | 120,498 | -2.0% | 0.09% | +33.8% |
Q1 2020 | $16,203,000 | -16.5% | 123,001 | +1.7% | 0.07% | +4.6% |
Q4 2019 | $19,407,000 | – | 120,902 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |